Skip to Main Content

Paper Details

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.
PLoS One
19
2018
CUDC-907, GSK2126458, NF2, NF2 gene, Neurofibromatosis 2, Panobinostat, benign tumors, isogenic schwannoma and meningioma cell systems, meningioma, meningioma and schwannoma, meningioma and schwannoma cell systems, meningiomas, merlin, merlin deficient, neurofibromatosis type 2, rare, schwann cell, schwann cell systems, schwannoma, schwannoma and meningioma, schwannoma and meningioma cell systems, schwannomas, transcriptome, tumor, tumor suppressor syndrome, tumor syndrome
Author NameAffiliation
Robert J Allaway
Jaishri O BlakeleyJohns Hopkins University School of Medicine
Justin Guinney
Justin Guinney
James F GusellaMassachusetts General Hospital and Harvard Medical School
Stephen J HaggartyMassachusetts General Hospital and Harvard Medical School
Gary L JohnsonUniversity of North Carolina School of Medicine
Salvatore La RosaChildren's Tumor Foundation
Anat Stemmer-RachamimovMassachusetts General Hospital and Harvard Medical School
Wen-Ning ZhaoMassachusetts General Hospital and Harvard Medical School
  • 1 - 10

Datasets

Release 1.2